Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2024-06-20 00:00:00 ET · period of report 2024-06-17 · accession 0000950170-24-075718 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-06-20 | 2024-06-17 | NTLA | Verwiel Frank | Dir | S - Sale | $25.00 | -1,505 | 17.9K | -8% | -$37.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-17 | S | D | 1,505 | $25.00 | 17,948 | D | — | — |